On-going Studies

A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease

The primary clinical hypothesis is that long-term exposure of evolocumab will be safe and well tolerated in subjects with clinically evident atherosclerotic cardiovascular disease (CVD)


Neurocare, Center for Sleep

70 Wells Avenue, Newton MA 02459
ph. 617-796-7766
fax 617-796-9099

© 2018 Neurocare, Inc.  All rights reserved.

  • Facebook - Black Circle